RF
ABBV icon

Resolute Financial’s AbbVie ABBV Stock Holding History

Resolute Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$756K Buy
4,679
+293
+7% +$44.9K 0.64% 38
2022
Q3 		$589K Buy
4,386
+10
+0.2% +$1.44K 0.56% 41
2022
Q2 		$670K Buy
4,376
+184
+4% +$28.1K 0.58% 39
2022
Q1 		$680K Sell
4,192
-454
-10% -$65.9K 0.55% 44
2021
Q4 		$629K Buy
+4,646
New +$549K 0.47% 48

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Resolute Financial's ABBV Position: Q4 2022 in Review

Resolute Financial increased its AbbVie (ABBV) stake by 6.7% in Q4 2022, buying an estimated $44.9K and bringing the position to 4,679 shares worth $756K. The position accounts for 0.64% of the portfolio, ranked #38.

Resolute Financial first reported a position in ABBV in Q4 2021 and has held it in 5 quarters since. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Resolute Financial held 4,679 shares of AbbVie worth $756K as of Q4 2022.
  • Resolute Financial bought 293 AbbVie shares in Q4 2022, an estimated $44.9K.
  • AbbVie made up 0.64% of Resolute Financial's portfolio in Q4 2022, its #38 holding.
  • Resolute Financial first reported a position in AbbVie in Q4 2021 and has held it in 5 quarters since.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Resolute Financial's 13F filing for Q4 2022, filed 13 Feb 2023.